ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
yelrom
|
5.5K |
2.7M |
12 |
05/12/20 |
05/12/20 |
ASX - By Stock
|
5.5K
|
2.7M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
yelrom
|
572 |
252K |
12 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
572
|
252K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
yelrom
|
572 |
252K |
12 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
572
|
252K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Recommends Continuation of Phase 3 COVID-19 Trial
|
|
yelrom
|
299 |
139K |
7 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
299
|
139K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
yelrom
|
10K |
3.0M |
11 |
29/11/20 |
29/11/20 |
ASX - By Stock
|
10K
|
3.0M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
AGM Discussion
|
|
yelrom
|
254 |
100K |
14 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
254
|
100K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
options help question with image !
|
|
yelrom
|
27 |
7.0K |
0 |
25/11/20 |
25/11/20 |
ASX - By Stock
|
27
|
7.0K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
options help question with image !
|
|
yelrom
|
27 |
7.0K |
2 |
25/11/20 |
25/11/20 |
ASX - By Stock
|
27
|
7.0K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
yelrom
|
392 |
159K |
46 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
392
|
159K
|
46
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
yelrom
|
13K |
5.0M |
23 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.8M |
28 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
17K
|
6.8M
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
yelrom
|
392 |
159K |
33 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
392
|
159K
|
33
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
yelrom
|
3.1K |
1.4M |
11 |
17/11/20 |
17/11/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
yelrom
|
13K |
5.0M |
39 |
15/11/20 |
15/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
39
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
yelrom
|
392 |
159K |
7 |
12/11/20 |
12/11/20 |
ASX - By Stock
|
392
|
159K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
yelrom
|
3.1K |
1.4M |
27 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment
|
|
yelrom
|
445 |
193K |
34 |
27/10/20 |
27/10/20 |
ASX - By Stock
|
445
|
193K
|
34
|
|
ASX - By Stock
|
MSB |
Re:
Speculative 8-month target - $33.00 MSB for GVHD, COVID ARDS
|
|
yelrom
|
139 |
95K |
114 |
14/10/20 |
14/10/20 |
ASX - By Stock
|
139
|
95K
|
114
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
yelrom
|
17K |
6.8M |
2 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
17K
|
6.8M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Investigation of Mesoblast Limited (MESO) on Behalf of Investors
|
|
yelrom
|
53 |
29K |
4 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
53
|
29K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
yelrom
|
13K |
5.0M |
10 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
13K
|
5.0M
|
10
|
|